Breathing Machine's impact on key muscle under scrutiny in COPD study

NCT ID NCT07193017

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at how long-term use of a BiPAP machine affects the diaphragm—the main breathing muscle—in people with advanced COPD. Researchers will use ultrasound to measure diaphragm thickness and movement over 6 weeks and 12 months in 30 patients. The goal is to learn whether BiPAP helps or harms diaphragm function, which could guide future treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Biphasic positive airway pressure (BiPAP) device
What this could lead to
If successful, this could help doctors understand how BiPAP affects the diaphragm in COPD, potentially leading to better treatment plans for advanced respiratory failure.
What could go wrong
This is a small, early-stage observational study with only 30 participants, so results may not apply to all COPD patients. It measures changes but does not test a new drug or cure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BIPAP BIPHASIC INTERMITTENT POSITIVE AIRWAY PRESSURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Demiroglu Bilim University, Department of Physiotherapy and Rehabilitation

    Istanbul, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.